Article Details
Retrieved on: 2024-02-26 18:11:55
Tags for this article:
Click the tags to see associated articles and topics
Summary
Fusion Pharmaceuticals is anticipated to exceed earnings forecasts based on past performance and biotech collaborations with AstraZeneca and Merck focusing on targeted radiopharmaceuticals and precision medicines.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here